
Idelalisib Effective Among Patients With Early Progression
Author(s) -
Catlin Nalley
Publication year - 2017
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000527111.15984.7c
Subject(s) - follicular lymphoma , idelalisib , medicine , chemoimmunotherapy , follicular phase , lymphoma , oncology , population , rituximab , ibrutinib , leukemia , environmental health , chronic lymphocytic leukemia